Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study Protocol: Observational Cohort Study to Improve Rebleeding Risk Stratification for Patients With Cirrhosis and Portal Hypertension on Non-selective Beta-blockers

NCT01751191 is registered in ClinicalTrials.gov with Hospital Clinic of Barcelona as lead sponsor.

NCT NCT01751191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01751191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study Protocol: Observational Cohort Study to Improve Rebleeding Risk Stratification for Patients With Cirrhosis and Portal Hypertension on Non-selective Beta-blockers
Lead sponsor
Hospital Clinic of Barcelona
Phase
Observational
Overall status
Completed
Start date
August 31, 2011
Completion date
December 31, 2012
Enrollment
338 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

liver cirrhosis, portal hypertension